CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
Cash flows from operating activities:
Net income	$ 379,890	$ 324,281
Adjustments to reconcile to net cash provided by operating activities
Depreciation and amortization	235,429	95,994
Deferred income taxes	(35,134)	20,623
Losses (gains) on sale of assets	1,136	(435)
Stock-based compensation	26,426	22,041
Pension contributions	(16,390)	(15,983)
Loss on extinguishment of debt	0	38,810
Gain on deal contingent derivatives	0	(12,505)
Product recall claim settlement, net of insurance proceeds received	0	(3,090)
Changes in assets and liabilities, net of acquisitions:
Trade receivables	(22,878)	(93,198)
Inventories	(84,140)	(92,705)
Accounts payable	(39,332)	(17,198)
Accruals for incentive compensation	(20,726)	(10,753)
Other current payables and accrued expenses	(12,161)	386
Other assets	(58,016)	(61,597)
Other liabilities	28,931	7,287
Net cash provided by operating activities	383,035	201,958
Cash flows from investing activities:
Cash paid for acquisitions, net of cash received	(49,065)	(22)
Additions to property, plant and equipment	(160,449)	(102,421)
Additions to intangible assets	(6,070)	0
Proceeds from life insurance contracts	1,890	1,837
Maturity of net investment hedges	0	(2,642)
Proceeds from disposal of assets	34,607	961
Proceeds from unwinding of cross currency swap derivative instruments	25,900	0
Contingent consideration paid	(4,655)	0
Net cash used in investing activities	(157,842)	(102,287)
Cash flows from financing activities:
Cash dividends paid to shareholders	(233,477)	(163,318)
Increase in revolving credit facility and short term borrowings	11	112,483
Deferred financing costs	0	(21,944)
Repayments on debt	(100,785)	(288,810)
Proceeds from issuance of long-term debt	0	2,926,414
Contingent consideration paid	(21,791)	0
Proceeds from sales of equity securities, net of issuance costs	0	2,268,965
Proceeds from pre-issuance hedges	0	12,505
Proceeds from issuance of stock in connection with stock options	200	0
Employee withholding taxes paid	(9,966)	(9,725)
Purchase of treasury stock	0	(15,475)
Net cash (used in) provided by financing activities	(365,808)	4,821,095
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(3,853)	(14,353)
Net change in cash, cash equivalents and restricted cash	(144,468)	4,906,413
Cash, cash equivalents and restricted cash at beginning of year	648,522	368,046
Cash, cash equivalents and restricted cash at end of period	504,054	5,274,459
Supplemental Disclosures:
Interest paid, net of amounts capitalized	122,121	91,874
Income taxes paid	98,819	86,672
Accrued capital expenditures	$ 15,826	$ 18,247